FOGAR, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.045
AS - Asia 10.483
EU - Europa 4.664
SA - Sud America 1.617
AF - Africa 1.537
OC - Oceania 150
Continente sconosciuto - Info sul continente non disponibili 148
Totale 35.644
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.149
SG - Singapore 3.413
CN - Cina 1.926
VN - Vietnam 1.415
HK - Hong Kong 1.062
BR - Brasile 981
IT - Italia 769
FI - Finlandia 475
PL - Polonia 471
BD - Bangladesh 420
FR - Francia 418
DE - Germania 400
SE - Svezia 301
IN - India 295
UA - Ucraina 210
RU - Federazione Russa 190
GB - Regno Unito 184
IQ - Iraq 172
NL - Olanda 172
CA - Canada 147
AR - Argentina 140
TR - Turchia 124
JP - Giappone 118
PK - Pakistan 116
MX - Messico 114
SA - Arabia Saudita 108
PH - Filippine 105
ID - Indonesia 91
ZA - Sudafrica 90
KR - Corea 84
CO - Colombia 76
EC - Ecuador 74
ES - Italia 72
VE - Venezuela 70
EG - Egitto 62
MA - Marocco 62
MY - Malesia 62
IE - Irlanda 58
AT - Austria 57
PY - Paraguay 57
UZ - Uzbekistan 56
JO - Giordania 53
CL - Cile 52
KZ - Kazakistan 52
LB - Libano 52
TH - Thailandia 51
TN - Tunisia 51
CI - Costa d'Avorio 50
KH - Cambogia 50
KE - Kenya 49
NP - Nepal 49
PA - Panama 49
AO - Angola 48
JM - Giamaica 48
GT - Guatemala 47
UG - Uganda 47
AE - Emirati Arabi Uniti 46
BJ - Benin 46
BO - Bolivia 46
CR - Costa Rica 46
BW - Botswana 45
BZ - Belize 44
DZ - Algeria 44
MD - Moldavia 44
PE - Perù 44
TW - Taiwan 44
AU - Australia 43
BY - Bielorussia 43
AZ - Azerbaigian 42
HR - Croazia 42
RO - Romania 42
GM - Gambi 41
PT - Portogallo 41
IR - Iran 40
ML - Mali 40
NO - Norvegia 40
PR - Porto Rico 40
PS - Palestinian Territory 40
DO - Repubblica Dominicana 39
KG - Kirghizistan 39
UY - Uruguay 39
AF - Afghanistan, Repubblica islamica di 38
CV - Capo Verde 38
CY - Cipro 38
CZ - Repubblica Ceca 38
ET - Etiopia 38
HU - Ungheria 38
YE - Yemen 38
AL - Albania 37
NI - Nicaragua 37
SN - Senegal 37
TT - Trinidad e Tobago 37
BE - Belgio 36
BG - Bulgaria 36
DJ - Gibuti 36
GF - Guiana Francese 36
LU - Lussemburgo 36
ME - Montenegro 36
AD - Andorra 35
CG - Congo 35
Totale 33.874
Salva come PNG Salva come JPEG
Città #
Singapore 2.106
Ashburn 1.968
San Jose 1.714
Fairfield 1.088
Chandler 1.084
Woodbridge 1.058
Ann Arbor 959
Hong Kong 947
Houston 812
Jacksonville 773
Wilmington 542
Cambridge 437
Ho Chi Minh City 424
Bytom 390
Seattle 378
Beijing 362
Los Angeles 355
Santa Clara 343
Boardman 330
Hanoi 296
Princeton 264
Helsinki 230
Des Moines 210
Lauterbourg 207
Medford 198
New York 178
Nanjing 165
Dong Ket 109
Guangzhou 109
Roxbury 106
Council Bluffs 105
San Diego 99
São Paulo 92
Da Nang 77
Milan 77
Buffalo 73
Munich 69
Rome 69
Baghdad 67
Dallas 65
Chicago 63
Tokyo 58
Orem 55
Haiphong 52
Nanchang 52
Amman 50
Padova 50
Tianjin 49
Abidjan 48
Dublin 48
Phnom Penh 48
Tashkent 48
Shenyang 47
Brooklyn 46
Frankfurt am Main 46
Kampala 46
Cotonou 44
Montreal 44
Nairobi 44
Panama City 43
London 42
Warsaw 42
Johannesburg 41
Shanghai 41
Atlanta 40
Jeddah 40
Bamako 39
Hebei 39
Luanda 39
Baku 38
Addis Ababa 36
Dakar 36
Denver 36
Andorra la Vella 35
Changsha 35
Djibouti 35
Managua 35
Riyadh 35
Bishkek 34
Guayaquil 34
Montevideo 34
San José 34
Vienna 34
Gaborone 33
Harare 33
Lima 33
Lusaka 33
Ulan Bator 33
Amsterdam 32
Antananarivo 32
Kingston 32
Kuala Lumpur 32
Phoenix 32
Lahore 31
Praia 31
Redondo Beach 31
San Francisco 31
Dushanbe 30
Hefei 30
Jiaxing 30
Totale 21.309
Salva come PNG Salva come JPEG
Nome #
Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when? 365
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 344
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 336
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 325
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 319
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 267
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 267
Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis. 266
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 263
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 263
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 262
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 260
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 259
Clinical utility of TPS, TPA and CA19-9 measurement in pancreatic cancer 257
Cystic Fluid Total Proteins, Low-Density Lipoprotein Cholesterol, Lipid Metabolites, and Lymphocytes: Worrisome Biomarkers for Intraductal Papillary Mucinous Neoplasms 256
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 254
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 249
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 248
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases. 245
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 245
Does serum CAR-3 play a role in pancreatic cancer diagnosis? 243
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 242
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 238
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 238
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 236
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 235
ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications 233
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 227
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 225
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 225
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 224
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 223
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 219
Comparison of two newly identified tumor markers (CAR-3 and DU-PAN-2) with CA 19-9 in patients with pancreatic cancer. 218
Mucopolysaccharidosis type VII diagnosed from a peripheral blood smear 218
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 217
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 215
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 213
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 212
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 209
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 209
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 205
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 205
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 204
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 203
Modulazione termica dell'espressione della subunità  catalitica della tossina difterica e delle sue varianti CRM176 e CRM197 nella terapia genica del carcinoma del pancreas 203
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 202
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 201
Urinary phospholipase A2 excretion in chronic pancreatic diseases 200
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 199
Neonatal lymphocyte subpopulations analysis and maternal preterm premature rupture of membranes: A pilot study 198
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 197
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 195
Urinary kallikrein excretion in chronic pancreatic diseases. 195
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 194
Effect of CagA status on the sensitivity of enzyme immunoassay in diagnosis Helicobacter pylori-infected children 193
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 193
T Cell Senescence by Extensive Phenotyping: An Emerging Feature of COVID-19 Severity 192
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 192
Deoxyribonuclease I serum activity in pancreatic cancer. 191
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 189
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 187
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 187
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 186
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 185
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 185
Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases. 183
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 183
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 183
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 182
Beta-cell function in pancreatic adenocarcinoma. 180
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 179
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 178
V75Q576 IL-4Ra variant and IL-4 -588T allele favor cagA-positive Helicobacter pylori infections. 178
Biological variability of lymphocyte subsets of human adults’ blood 178
Carcinogenetic potential of the WSR cagA region. 176
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 175
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 175
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 175
Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases. 174
Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art. 174
Synergistic effect of H. pylori infection and interleukin 12 polymorphisms for the development of gastric cancer 173
CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging 172
C-peptide pattern in patients with pancreatic cancer. 171
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 171
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 170
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 170
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 169
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 168
CAR-3 and CA 19-9 serum levels in pancreatic cancer: any differences between two epitopes of the same mucin-like glycoprotein? 167
SLC22A3 polymorphisms may influence overall patient survival-PANDORA study 167
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 166
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 165
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. 165
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 165
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 164
Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias. 163
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 161
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 161
[Biochemical markers of gastric functioning]. 160
Totale 20.991
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.978
article - articoli 42.993
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.844 0 368 146 82 60 161 50 143 89 31 185 529
2022/20232.282 438 260 26 267 387 363 8 122 275 26 81 29
2023/20241.088 42 136 111 75 68 176 71 97 27 56 101 128
2024/20254.716 22 234 259 207 652 100 186 291 465 176 877 1.247
2025/202617.374 668 1.468 2.220 2.091 1.776 720 2.546 1.639 1.836 1.136 739 535
2026/20271.083 774 309 0 0 0 0 0 0 0 0 0 0
Totale 35.644